Covered recipient · General Payments record
LINDA W BOYATT
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2025
$2,999.77
- Reported across 29 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $996.31 | 10 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $280.16 | 2 |
| Medtronic, Inc. | $138.67 | 1 |
| E.R. Squibb & Sons, L.L.C. | $122.09 | 1 |
| Axsome Therapeutics, Inc. | $121.82 | 1 |
| Abbott Laboratories | $121.18 | 1 |
| Penumbra, Inc. | $99.26 | 1 |
| Acerta Pharma LLC | $65.56 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $47.57 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $121.18 | 06/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240997828 | CMS |
| AstraZeneca Pharmaceuticals LP | $65.56 | 04/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206709317 | CMS |
| Axsome Therapeutics, Inc. | $121.82 | 08/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235764425 | CMS |
| Boston Scientific Corporation | $25.28 | 06/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1180980966 | CMS |
| Boston Scientific Corporation | $22.29 | 08/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1180980968 | CMS |
| E.R. Squibb & Sons, L.L.C. | $122.09 | 04/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184858019 | CMS |
| Janssen Biotech, Inc. | $133.96 | 05/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174866912 | CMS |
| Janssen Biotech, Inc. | $146.20 | 10/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174866926 | CMS |
| Medtronic, Inc. | $138.67 | 04/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1219760861 | CMS |
| Penumbra, Inc. | $99.26 | 04/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1177439972 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.